Dicerna Pharmaceuticals, Inc. (DRNA) At $12.48 Forms Top; Easterly Government Properties (DEA) SI Increased By 6.22%

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Logo

Dicerna Pharmaceuticals, Inc. (DRNA) formed multiple top with $12.98 target or 4.00% above today’s $12.48 share price. Dicerna Pharmaceuticals, Inc. (DRNA) has $659.21 million valuation. The stock decreased 0.16% or $0.02 during the last trading session, reaching $12.48. About 397,151 shares traded. Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) has risen 317.27% since June 14, 2017 and is uptrending. It has outperformed by 304.70% the S&P500. Some Historical DRNA News: ; 20/04/2018 – Alnylam Reaches Settlement Agreement with Dicerna Pharmaceuticals Resolving Trade Secret Misappropriation and Other Pending; 20/04/2018 – ADVISORY-Alert on Dicerna, Alnylam litigation settlement wrongly coded to American Lorain; 09/04/2018 – Dicerna Presenting at Conference Tomorrow; 30/05/2018 – Dicerna Doses First Primary Hyperoxaluria Patient with DCR-PHXC in Group B Portion of PHYOX Phase 1 Clinical Trial; 20/04/2018 – Alnylam: Dicerna to Be Restricted in Its Development of Certain Therapeutics for 18 Mos to Four Years; 08/03/2018 – DICERNA PHARMACEUTICALS INC – QTRLY SHR LOSS $0.90; 08/03/2018 Dicerna Pharmaceuticals 4Q Loss/Shr 90c; 20/04/2018 – DICERNA PHARMACEUTICALS – SETTLEMENT ALLOWS CO TO ADVANCE ALL KEY, PLANNED PIPELINE PROGRAMS; 14/05/2018 – Dicerna Pharmaceuticals Believes It Has Sufficient Cash Through 2019, Assuming No New Fundin; 03/04/2018 – Dicerna at HC Wainwright Global Biotechnology Conference Apr 10

Easterly Government Properties Inc (NYSE:DEA) had an increase of 6.22% in short interest. DEA’s SI was 2.84M shares in June as released by FINRA. Its up 6.22% from 2.68M shares previously. With 451,100 avg volume, 6 days are for Easterly Government Properties Inc (NYSE:DEA)’s short sellers to cover DEA’s short positions. The stock decreased 1.40% or $0.28 during the last trading session, reaching $19.67. About 465,759 shares traded or 8.36% up from the average. Easterly Government Properties, Inc. (NYSE:DEA) has declined 0.70% since June 14, 2017 and is downtrending. It has underperformed by 13.27% the S&P500. Some Historical DEA News: ; 08/05/2018 – EASTERLY GOVERNMENT PROPERTIES INC – SEES 2018 FFO PER SHARE — FULLY DILUTED BASIS $1.27 TO $1.31; 04/05/2018 – Easterly Government Properties Announces Quarterly Dividend; 08/05/2018 – EASTERLY GOVERNMENT PROPERTIES INC – FY 2018 GUIDANCE ASSUMES $450 MLN OF ACQUISITIONS, WEIGHTED HEAVILY TOWARDS SECOND HALF OF 2018; 22/04/2018 – DJ Easterly Government Properties Inc, Inst Holders, 1Q 2018 (DEA); 08/05/2018 – EASTERLY GOVERNMENT PROPERTIES INC DEA.N FY2018 FFO SHR VIEW $1.33 — THOMSON REUTERS l/B/E/S; 19/03/2018 EASTERLY GOVERNMENT SAID TO OFFER $58.6M SHRS VIA CITI, BTIG; 23/04/2018 – Research Report Identifies Signature Bank, Concert Pharmaceuticals, Easterly Government Properties, Hilltop, Columbia Banking S

Another recent and important Easterly Government Properties, Inc. (NYSE:DEA) news was published by Seekingalpha.com which published an article titled: “Young And In REITs: An Introduction To My Portfolio And Me” on May 21, 2018.

Among 6 analysts covering Easterly Government Properties (NYSE:DEA), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Easterly Government Properties had 13 analyst reports since September 7, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, May 23 by Jefferies. The stock of Easterly Government Properties, Inc. (NYSE:DEA) earned “Buy” rating by Jefferies on Tuesday, September 5. The firm earned “Buy” rating on Friday, December 15 by SunTrust. SunTrust maintained the shares of DEA in report on Monday, January 22 with “Buy” rating. Zacks upgraded Easterly Government Properties, Inc. (NYSE:DEA) on Monday, September 7 to “Buy” rating. The company was initiated on Wednesday, October 5 by Jefferies. As per Monday, January 9, the company rating was downgraded by Raymond James. As per Monday, November 13, the company rating was maintained by Citigroup. Jefferies maintained Easterly Government Properties, Inc. (NYSE:DEA) on Monday, June 26 with “Buy” rating. The rating was maintained by SunTrust on Friday, November 3 with “Buy”.

Easterly Government Properties, Inc

Since December 18, 2017, it had 1 insider purchase, and 4 selling transactions for $1.57 million activity. $150,000 worth of Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) was sold by Weissman James B. Brown Bob D also sold $145,035 worth of Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) shares. $2.00 million worth of stock was bought by Bain Capital Life Sciences Investors – LLC on Monday, December 18.

Among 9 analysts covering Dicerna Pharmaceuticals (NASDAQ:DRNA), 4 have Buy rating, 0 Sell and 5 Hold. Therefore 44% are positive. Dicerna Pharmaceuticals had 25 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) has “Neutral” rating given on Thursday, June 30 by Chardan Capital Markets. The stock has “Hold” rating by FBR Capital on Tuesday, March 27. The company was maintained on Monday, August 15 by Chardan Capital Markets. The firm has “Buy” rating given on Monday, August 10 by Stifel Nicolaus. The stock of Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) earned “Buy” rating by SunTrust on Monday, February 5. The stock of Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) earned “Buy” rating by Stifel Nicolaus on Tuesday, May 10. The firm has “Buy” rating by Cowen & Co given on Wednesday, August 16. Stifel Nicolaus maintained it with “Buy” rating and $17 target in Friday, March 9 report. The stock of Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) has “Buy” rating given on Wednesday, November 11 by Stifel Nicolaus. Chardan Capital Markets initiated Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) on Friday, March 9 with “Hold” rating.

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Institutional Positions Chart